Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study

R Brauer, B Alfageh, JE Blais, EW Chan… - The Lancet …, 2021 - thelancet.com
Summary Background The WHO Comprehensive Mental Health Action Plan 2013–2030
encourages routine collection and reporting of a set of essential mental health indicators …

Prevalence of mental, neurological, and substance use disorders in China and India: a systematic analysis

AJ Baxter, FJ Charlson, HG Cheng, R Shidhaye… - The Lancet …, 2016 - thelancet.com
Background Population-representative prevalence data for mental, neurological, and
substance use disorders are essential for evidence-based decision making. As a …

International trends in antipsychotic use: a study in 16 countries, 2005–2014

Ó Hálfdánarson, H Zoëga, L Aagaard… - European …, 2017 - Elsevier
The objective of this study was to assess international trends in antipsychotic use, using a
standardised methodology. A repeated cross-sectional design was applied to data extracts …

The increasing global health priority of substance use in young people

L Degenhardt, E Stockings, G Patton, WD Hall… - The Lancet …, 2016 - thelancet.com
Substance use in young people (aged 10–24 years) might disrupt key periods of transition
that occur as the adolescent brain undergoes cognitive and emotional development, and …

New psychoactive substances: challenges for drug surveillance, control, and public health responses

A Peacock, R Bruno, N Gisev, L Degenhardt, W Hall… - The Lancet, 2019 - thelancet.com
The rapid emergence since the mid-2000s of a large and diverse range of substances
originally designed as legal alternatives to more established illicit drugs (pragmatically …

Psychotropic medication use in Australia, 2007 to 2015: changes in annual incidence, prevalence and treatment exposure

J Brett, EA Karanges, B Daniels… - Australian & New …, 2017 - journals.sagepub.com
Objective: To examine changes in annual patterns of psychotropic medication use in
Australia from 2007 to 2015. Methods: We used a 10% sample of individual-level nationwide …

Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011

CP Stephenson, E Karanges… - Australian & New …, 2013 - journals.sagepub.com
Objective: This study examined longitudinal trends in the dispensing of psychotropic
medications in Australia from January 2000 to December 2011. Method: Dispensing data for …

Prevalence of mental disorders in China: a cross-sectional epidemiological study

Y Huang, YU Wang, H Wang, Z Liu, X Yu, J Yan… - The Lancet …, 2019 - thelancet.com
Summary Background The China Mental Health Survey was set up in 2012 to do a
nationally representative survey with consistent methodology to investigate the prevalence …

Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010

S Ilyas, J Moncrieff - The British Journal of Psychiatry, 2012 - cambridge.org
BackgroundIncreasing rates of prescriptions for antidepressants, antipsychotics and
stimulants have been reported from various countries. AimsTo examine trends in …

Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys

PS Wang, S Aguilar-Gaxiola, J Alonso… - The Lancet, 2007 - thelancet.com
Background Mental disorders are major causes of disability worldwide, including in the low-
income and middle-income countries least able to bear such burdens. We describe mental …